A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer
Jafrin Jobayer Sonju, Achyut Dahal, Sitanshu S. Singh, Xin Gu, William D. Johnson, Chandra Mohan Reddy Muthumula, Sharon A. Meyer, Seetharama D. Jois
Topics & Concepts
DoxorubicinLiposomePeptidomimeticConjugateDrug deliveryIn vivoPharmacologyChemistryCytotoxic T cellTargeted drug deliveryCancer cellCytotoxicityLigand (biochemistry)DrugIn vitroCancerBiochemistryChemotherapyMedicineReceptorBiologyInternal medicineOrganic chemistryBiotechnologyMathematical analysisPeptideMathematicsNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsAdvanced biosensing and bioanalysis techniques